glp-1 glp-2 dual agonist PDB-101: Molecule of the Month: Receptor Agonists Mechanisms of action of GLP-1
Description
Incretin-Based Therapy and Type 2 Diabetes

In obesity and type 2 diabetes mellitus (T2DM): 5.1% had residual gastric contents after no solids for 14 hr, n=371

H.RendellM

[DOI] [PMC free article] [PubMed] [Google Scholar] 107